BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

941 related articles for article (PubMed ID: 31230614)

  • 21. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
    Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer.
    Rozenholc A; Samouelian V; Warkus T; Gauthier P; Provencher D; Sauthier P; Gauthier F; Drakopoulos P; Cormier B
    Gynecol Oncol; 2019 Jun; 153(3):500-504. PubMed ID: 30902369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
    Nagar H; Wietek N; Goodall RJ; Hughes W; Schmidt-Hansen M; Morrison J
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013021. PubMed ID: 34106467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC).
    Desai PH; Hughes P; Tobias DH; Tchabo N; Heller PB; Dise C; Slomovitz BM
    Gynecol Oncol; 2014 Nov; 135(2):196-200. PubMed ID: 25175452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.
    Body N; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
    Gynecol Oncol; 2018 Aug; 150(2):267-273. PubMed ID: 29909967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging.
    Persson J; Salehi S; Bollino M; Lönnerfors C; Falconer H; Geppert B
    Eur J Cancer; 2019 Jul; 116():77-85. PubMed ID: 31181536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbon nanoparticles combined with indocyanine green for sentinel lymph node detection in endometrial carcinoma.
    Liang S; Wang Z; Chen J; Yang X; Liang X; Sun X; Li X; Zhou R; Li Y; Wang J
    J Surg Oncol; 2021 Sep; 124(3):411-419. PubMed ID: 34086291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
    Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
    Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
    Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
    Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic Sentinel Node Mapping in Endometrial Cancer After Hysteroscopic Injection of Indocyanine Green.
    Martinelli F; Ditto A; Bogani G; Signorelli M; Chiappa V; Lorusso D; Haeusler E; Raspagliesi F
    J Minim Invasive Gynecol; 2017 Jan; 24(1):89-93. PubMed ID: 27725278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.
    Papadia A; Imboden S; Siegenthaler F; Gasparri ML; Mohr S; Lanz S; Mueller MD
    Ann Surg Oncol; 2016 Jul; 23(7):2206-11. PubMed ID: 26790667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer.
    Buda A; Bussi B; Di Martino G; Di Lorenzo P; Palazzi S; Grassi T; Milani R
    J Minim Invasive Gynecol; 2016 Feb; 23(2):265-9. PubMed ID: 26455525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel Node Biopsy in Endometrial Cancer With Dual Cervical and Fundal Indocyanine Green Injection.
    Ruiz R; Gorostidi M; Jaunarena I; Goiri C; Aguerre J; Lekuona A
    Int J Gynecol Cancer; 2018 Jan; 28(1):139-144. PubMed ID: 29194192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99
    Papadia A; Zapardiel I; Bussi B; Ghezzi F; Ceccaroni M; De Ponti E; Elisei F; Imboden S; de la Noval BD; Gasparri ML; Di Martino G; De Santiago J; Mueller M; Vecchione F; Dell'Orto F; Buda A
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):475-480. PubMed ID: 27812854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipose-only sentinel lymph nodes: a finding during the adaptation of a sentinel lymph node mapping algorithm with indocyanine green in women with endometrial cancer.
    Harold JA; Uyar D; Rader JS; Bishop E; Nugent M; Simpson P; Bradley WH
    Int J Gynecol Cancer; 2019 Jan; 29(1):53-59. PubMed ID: 30640684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer: Comparison of Real-Time Fluorescence With Indocyanine Green and Methylene Blue.
    Buda A; Di Martino G; Vecchione F; Bussi B; Dell'Anna T; Palazzi S; Cantù MG; Marchette MD; Milani R
    Int J Gynecol Cancer; 2015 Oct; 25(8):1513-8. PubMed ID: 26397069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: A single center evaluation over 200 cases.
    Martinelli F; Ditto A; Signorelli M; Bogani G; Chiappa V; Lorusso D; Scaffa C; Recalcati D; Perotto S; Haeusler E; Raspagliesi F
    Gynecol Oncol; 2017 Sep; 146(3):525-530. PubMed ID: 28625394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting.
    Vidal F; Leguevaque P; Motton S; Delotte J; Ferron G; Querleu D; Rafii A
    Int J Gynecol Cancer; 2013 Sep; 23(7):1237-43. PubMed ID: 23839245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.